Literature DB >> 20077161

Tyrosine phosphatase SHP-1 in allergic and anaphylactic inflammation.

Zhou Zhu1, Sun Young Oh, You Sook Cho, Li Zhang, Yoon-Keun Kim, Tao Zheng.   

Abstract

Protein tyrosine phosphatase SHP-1 is an essential regulatory molecule in many different signaling pathways. The biological importance of SHP-1 is underscored by the motheaten mutant mouse strains with immunological disorders involving multiple organs and by the close association of aberrant SHP-1 expression with several human diseases. Recent studies provided some compelling evidence that supports a role of SHP-1 in regulating mast cell development and function and also in regulating type 2 allergic inflammatory responses in both innate and adaptive immune responses. In this article, we summarize the recent advancement of our understanding of this interesting phosphatase in the important area of allergic inflammation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20077161      PMCID: PMC2954886          DOI: 10.1007/s12026-009-8134-5

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  54 in total

1.  IgE antibody up-regulates high affinity IgE binding on murine bone marrow-derived mast cells.

Authors:  C Hsu; D MacGlashan
Journal:  Immunol Lett       Date:  1996-09       Impact factor: 3.685

2.  Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1.

Authors:  R F Paulson; S Vesely; K A Siminovitch; A Bernstein
Journal:  Nat Genet       Date:  1996-07       Impact factor: 38.330

3.  Diminished cell proliferation associated with the death-protective activity of Bcl-2.

Authors:  C Borner
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

4.  Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation.

Authors:  B F Gibbs; H Haas; F H Falcone; C Albrecht; I B Vollrath; T Noll; H H Wolff; U Amon
Journal:  Eur J Immunol       Date:  1996-10       Impact factor: 5.532

5.  Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils.

Authors:  D MacGlashan; J M White; S K Huang; S J Ono; J T Schroeder; L M Lichtenstein
Journal:  J Immunol       Date:  1994-03-15       Impact factor: 5.422

6.  "Viable motheaten," a new allele at the motheaten locus. I. Pathology.

Authors:  L D Shultz; D R Coman; C L Bailey; W G Beamer; C L Sidman
Journal:  Am J Pathol       Date:  1984-08       Impact factor: 4.307

7.  Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene.

Authors:  H W Tsui; K A Siminovitch; L de Souza; F W Tsui
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

8.  The viable motheaten (mev) mouse--a new model for arthritis.

Authors:  J Kovarik; L Kuntz; B Ryffel; J F Borel
Journal:  J Autoimmun       Date:  1994-10       Impact factor: 7.094

9.  Motheaten mice--an animal model with an inherited form of interstitial lung disease.

Authors:  G A Rossi; G W Hunninghake; O Kawanami; V J Ferrans; C T Hansen; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1985-01

10.  B and T cells are not required for the viable motheaten phenotype.

Authors:  C C Yu; H W Tsui; B Y Ngan; M J Shulman; G E Wu; F W Tsui
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Different partners, opposite outcomes: a new perspective of the immunobiology of indoleamine 2,3-dioxygenase.

Authors:  Ciriana Orabona; Maria Teresa Pallotta; Ursula Grohmann
Journal:  Mol Med       Date:  2012-07-18       Impact factor: 6.354

Review 2.  Modulation of IL-4/IL-13 cytokine signaling in the context of allergic disease.

Authors:  Archana Shankar; Jaclyn W McAlees; Ian P Lewkowich
Journal:  J Allergy Clin Immunol       Date:  2022-08       Impact factor: 14.290

Review 3.  Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy.

Authors:  Jie Pan; Lisha Zhou; Chenyang Zhang; Qiang Xu; Yang Sun
Journal:  Signal Transduct Target Ther       Date:  2022-06-04

Review 4.  Toll-like receptors, triggering receptor expressed on myeloid cells family members and receptor for advanced glycation end-products in allergic airway inflammation.

Authors:  Sannette C Hall; Devendra K Agrawal
Journal:  Expert Rev Respir Med       Date:  2016-01-20       Impact factor: 3.772

5.  Hepatocyte SHP-1 is a Critical Modulator of Inflammation During Endotoxemia.

Authors:  Anupam Adhikari; Caroline Martel; André Marette; Martin Olivier
Journal:  Sci Rep       Date:  2017-05-22       Impact factor: 4.379

6.  SHP1-mediated cell cycle redistribution inhibits radiosensitivity of non-small cell lung cancer.

Authors:  Rubo Cao; Qian Ding; Pindong Li; Jun Xue; Zhenwei Zou; Jing Huang; Gang Peng
Journal:  Radiat Oncol       Date:  2013-07-10       Impact factor: 3.481

7.  Alterations of cell cycle control proteins SHP‑1/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cells.

Authors:  Gang Peng; Ru-Bo Cao; Yue-Hua Li; Zhen-Wei Zou; Jing Huang; Qian Ding
Journal:  Mol Med Rep       Date:  2014-08-07       Impact factor: 2.952

8.  SHP-1 suppresses the antiviral innate immune response by targeting TRAF3.

Authors:  Doudou Hao; Yu Wang; Liuyan Li; Gui Qian; Jing Liu; Manman Li; Yihua Zhang; Ruixue Zhou; Dapeng Yan
Journal:  FASEB J       Date:  2020-07-23       Impact factor: 5.191

9.  Ets-2 deletion in myeloid cells attenuates IL-1α-mediated inflammatory disease caused by a Ptpn6 point mutation.

Authors:  Sarang Tartey; Prajwal Gurung; Rajendra Karki; Amanda Burton; Paul Hertzog; Thirumala-Devi Kanneganti
Journal:  Cell Mol Immunol       Date:  2020-03-19       Impact factor: 22.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.